金石亚药：子公司双氯芬酸钠缓释片通过仿制药一致性评价

Core Viewpoint - The announcement indicates that the subsidiary Zhejiang Di'er Pharmaceutical Co., Ltd. has successfully passed the consistency evaluation of quality and efficacy for its Diclofenac Sodium Sustained-release Tablets (0.1g specification) [1] Group 1: Product Approval - The drug registration standard number is YBH28882025, and the original drug approval number is National Drug Standard H20083921 [1] - The marketing authorization holder, Zhejiang Di'er Pharmaceutical Co., Ltd., has received the approval notice from the National Medical Products Administration [1] - The notice number for the drug supplementary application approval is 2025B05105 [1]